Cell & Gene Therapy Commercial Insight - March 2020

10.18609/cgti.2020.076

Published: 23 May 2020
Mark Curtis, Richard Philipson

Providing a critical overview of the sector’s commercial development: M&As, licensing agreements & collaborations, financial results, IPOs and clinical/regulatory updates, with commentary from our Expert Contributors.